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Abstract
Background: Population-based birth defects surveillance is a core public health activity in the United States (U.S.);
however, the lack of national data quality standards has limited the use of birth defects surveillance data across
state programs. Development of national standards will facilitate data aggregation and utilization across birth
defects surveillance programs in the U.S.
Methods: Based on national standards for other U.S. public health surveillance programs, existing National Birth
Defects Prevention Network (NBDPN) guidelines for conducting birth defects surveillance, and information from
birth defects surveillance programs regarding their current data quality practices, we developed 11 data quality
measures that focused on data completeness (n = 5 measures), timeliness (n = 2), and accuracy (n = 4). For each
measure, we established tri-level performance criteria (1 = rudimentary, 2 = essential, 3 = optimal). In January 2014,
we sent birth defects surveillance programs in each state, District of Columbia, Puerto Rico, Centers for Disease
Control and Prevention (CDC), and the U.S. Department of Defense Birth and Infant Health Registry an invitation to
complete a self-administered NBDPN Standards Data Quality Assessment Tool. The completed forms were
electronically submitted to the CDC for analyses.
Results: Of 47 eligible population-based surveillance programs, 45 submitted a completed assessment tool. Two of
the 45 programs did not meet minimum inclusion criteria and were excluded; thus, the final analysis included
information from 43 programs. Average scores for four of the five completeness performance measures were above
level 2. Conversely, the average scores for both timeliness measures and three of the four accuracy measures were
below level 2. Surveillance programs using an active case-finding approach scored higher than programs using
passive case-finding approaches for the completeness and accuracy measures, whereas their average scores were
lower for timeliness measures.
Conclusions: This initial, nation-wide assessment of data quality across U.S. population-based birth defects surveillance
programs highlights areas for improvement. Using this information to identify strengths and weaknesses, the
birth defects surveillance community, working through the NBDPN, can enhance and implement a consistent
set of standards that can promote uniformity and enable surveillance programs to work towards improving the
potential of these programs.
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Background
Collectively, major structural birth defects are a com-
mon, costly, and critical public health challenge. In the
United States (U.S.), one in every 33 babies is born with
at least one of these birth defects, and one in five infants
will die in their first year of life as a result of their birth
defect [1, 2]. Timely and accurate population-based data
on birth defects can contribute to early identification of
environmental concerns, determination of etiologic
agents, evaluation of prevention programs, estimation of
prevalence, assessment of disparities, and timely referral
to services for those with birth defects, with the hope of
improving outcomes.
Although the U.S. system of national birth registration
serves as an important data source for a number of
health indicators, the information collected on birth
defects is limited with both low sensitivity and specificity
[3–5]. Instead, birth defect data in the United States are
obtained from state or sub-state population-based birth
defects surveillance programs [6].
A major challenge to using birth defects surveillance
data effectively on a national level has been the lack of
core data quality standards across birth defects surveil-
lance programs. This lack of uniformity across pro-
grams limits the number of surveillance programs that
can provide high quality data to produce national
prevalence estimates for birth defects in the United
States [7, 8].
Experience from other public health data collection
programs in the United States, such as vital statistics or
cancer, demonstrates the positive impact of establishing
standards [9, 10]. Comparable data on live births, deaths,
and stillbirths as well as cancer incidence, are available
at the state and national level as the result of concerted
collaborative efforts among all states and with strong
involvement and financial support from our federal
government.
As an initial step toward standards for birth defects
surveillance in the United States, the National Birth
Defects Prevention Network (NBDPN) published guide-
lines for conducting birth defects surveillance in 2004
[11]. Although these guidelines have been instrumental
in assisting states to develop or enhance the operation of
their birth defects surveillance programs, the absence of
national standards for birth defects surveillance with
established benchmarks to improve data quality and util-
ity has limited the application of such surveillance data
to improve the health of affected populations. To ad-
dress this limitation, the NBDPN established a work-
group to develop national standards for quality and
utility of population-based birth defects surveillance data
in the United States. This paper focuses on our experi-
ence with development and implementation of these
data quality standards.
Methods
We planned a descriptive study to develop and test a
data quality assessment tool for population-based birth
defect surveillance programs.
Development of the data quality assessment tool
The NBDPN Standards Workgroup queried existing
birth defects surveillance programs regarding their data
quality practices by contacting program managers on
the NBDPN state birth defects contact list. Current
standards for other public health surveillance programs
(e.g., cancer registries, immunization programs, and
birth defects surveillance programs in other countries)
were also reviewed. The information collected, along
with the existing NBDPN guidelines for conducting
birth defects surveillance, provided the basis for data
quality measures that focused on three attributes: com-
pleteness, timeliness, and accuracy. Completeness was
defined as the extent to which all possible cases are
captured and the information collected on each case is
all-inclusive and comprehensive. Timeliness was de-
fined as the extent to which case reporting or acquisi-
tion are rapid, prompt, and responsive. Lastly, accuracy
was defined as the extent to which data elements are
exact, correct, and valid [12].
Recognizing the variability in data collection approaches
and data quality practices among U.S. population-based
birth defects surveillance programs, we established tri-level
performance criteria for each data quality measure. The
criteria established for level 1 reflected a rudimentary level
of performance by a birth defects surveillance program,
those for level 2 reflected an essential level of performance,
and those for level 3 represented the optimal level of per-
formance. Our expectation was that the majority of birth
defects surveillance programs in the United States should
be able to achieve level 2 on all measures.
Once the criteria were established for each data quality
measure, we developed a self-administered Data Quality
Assessment Tool to assess a state surveillance program’s
performance in data completeness, timeliness, and ac-
curacy (Additional file 1). Early drafts of the tool were
shared with selected state surveillance programs and
during the 2013 NBDPN annual meeting to obtain feed-
back. A revised tool was piloted in June 2013 by 19 state
surveillance programs who volunteered staff to complete
the tool and provide comments. Additional comments
were used to further refine the tool; it was finalized in
January 2014 with 11 data quality measures (Table 1).
Five of these measures pertained to completeness: list of
birth defects monitored, pregnancy outcomes included,
case identification reporting sources used, ascertainment
period for case identification, and data elements col-
lected. Two measures focused on timeliness with which
case data were completed, and four measures focused on
Anderka et al. BMC Public Health  (2015) 15:925 Page 2 of 7
accuracy: case diagnosis verification procedures, scope
of birth defects verified, level of expertise of individuals
who perform case diagnosis verification, and database
quality assurance process. Ad-hoc subgroups were formed
to further examine the list of reportable birth defects and
data elements. Finally, the self-administered tool was cre-
ated as a fillable Adobe Acrobat form.
Data collection and analysis
In January 2014, we e-mailed birth defect program
contacts from the 50 states, District of Columbia (DC),
Puerto Rico (PR), Centers for Disease Control and Pre-
vention (CDC), and U.S. Department of Defense Birth
and Infant Health Registry (DOD) (n = 54) inviting
them to complete the NBDPN Standards Data Quality
Assessment Tool for their population-based birth de-
fects programs. Follow-up e-mails and phone calls
were conducted to remind programs to complete the
tool. The completed Adobe Acrobat forms were elec-
tronically submitted to CDC for processing. Informa-
tion submitted was exported to SAS 9.3 (Cary, NC) for
analyses.
Table 1 National Birth Defects Prevention Network (NBDPN) levels of data quality performance measures for completeness,
timeliness, and accuracy
NBDPN Data Quality (DQ) Performance
Measures
Level 1 Level 2 Level 3
Completeness DQ1.1 Types of data sources
used systematically and
routinely to identify potential
cases at a population-based
level
Each of the following
sources:
The data sources in level 1 and any
additional sources of natal or
postnatal data
The data sources in levels 1 and 2,
as well as routine reporting from




• Vital record data
• Additional source for
case identification
DQ1.2 Birth defects included
using standard NBDPN case
definitions a
All of the NBDPN “core”
birth defects
All of the NBDPN “recommended”
birth defects
Major structural malformations
beyond those birth defects
identified on the NBDPN list
DQ1.3 Pregnancy outcomes
included








1 month of age
Identification of cases diagnosed
through 1 year of age
Identification of cases diagnosed
beyond 1 year of age
DQ1.5 Data elements
collected a
All “core” data elements All “recommended” data elements All “enhanced” data elements
Timeliness DQ2.1 Time of case data
completion for NBDPN
“core” list
≥75 % of all “core”
NBDPN birth defects -
reported cases complete
within 2 years of delivery.
≥95 % of all “core” NBDPN birth
defects - reported cases complete
within 2 years of delivery.
≥99 % of all “core” NBDPN birth
defects - reported cases complete
within 2 years of delivery.
DQ2.2 Time of case data
completion for NBDPN
“recommended” list




2 years of delivery.
≥95 % of all “recommended”
NBDPN birth defects list-reported
cases complete within 2 years of
delivery.
≥99 % of a “recommended” NBDPN
birth defects list-reported cases
complete within 2 years of delivery.
Accuracy DQ3.1 Data quality







Verification using “some” method,
e.g., clinical case report from a
specialty clinic, agreement across
multiple data sources, agreement
between procedure and diagnostic
codes, laboratory reports
Verification using method beyond
level 2, e.g., medical records





Verification for all “core” birth
defects
Verification for all “recommended”
birth defects
DQ3.3 Level of expertise for
individuals who perform
case diagnosis verification
Staff with no or minimal
disease coding or clinical
expertise perform routine
case reviews
Staff with expertise in disease
coding or clinical training perform
routine case reviews
Clinical geneticist, dysmorphologist
or other high level expert







Quality checks are performed for
“recommended” NBDPN data
elements.
Quality checks are performed for
“enhanced” NBDPN data elements.
aNBDPN list of birth defects and data elements are available at www.nbdpn.org
bSee supplementary material for a list of the data sources
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Eligible programs had to conduct population-based
birth defect surveillance using active or passive case
finding. A birth defects surveillance program was con-
sidered an active case-finding program if staff visit case
identification sources (medical record abstraction) to
collect original data on birth defects cases, and a passive
case-finding program if the surveillance program relies
on administrative databases or hospital reporting to
identify birth defects cases with or without case
verification.
To be included in the analyses a program must have
met level 1 for data quality measure 1.1 [types of data
sources used to identify potential cases] and have
achieved an overall average score on all measures of at
least 1. We calculated the average performance score for
each measure and for the data quality attributes (com-
pleteness, timeliness, and accuracy) overall and by case-
finding approach for each participating program.
Results
Of the 50 states and four other programs in the United
States that could potentially complete the Data Quality
Assessment tool, 47 had eligible population-based birth
defects surveillance programs. Of these, 45 programs
submitted their completed assessment tool (96 %
participation), but information from two programs were
excluded since they did not meet minimum inclusion
criteria. Therefore, the final analysis included informa-
tion from 43 programs. The 17 programs categorized as
using an active case-finding approach were: Arizona,
Arkansas, California, Delaware, Georgia (Metropolitan
Atlanta surveillance program operated by the CDC),
Hawaii, Iowa, Louisiana, Massachusetts, Minnesota,
New Hampshire, North Carolina, Oklahoma, Puerto
Rico, South Carolina, Texas, and Utah. The 26 programs
categorized as using passive case-finding were: Alaska,
Colorado, Connecticut, DOD, Florida, Georgia (full state,
operated by Georgia Department of Health), Illinois,
Indiana, Kansas, Kentucky, Maine, Maryland, Michigan,
Mississippi, Nebraska, New Jersey, New Mexico, New
York, North Dakota, Ohio, Oregon, Rhode Island,
Vermont, Virginia, West Virginia, and Wisconsin.
The average scores for each NBDPN data quality
measure for all 43 birth defects surveillance programs
combined are presented in Table 2. The average score
for each completeness performance measure was above
level 2, except for data quality measure 1.5 (data ele-
ments collected). The average scores for both timeliness
performance measures were below level 2, as were those
for each accuracy measure, except for data quality
Table 2 Average scores for completeness, timeliness, and accuracy overall and by program case-finding methodology
Data Quality (DQ) Performance Measures Overall - All







DQ1: Completeness DQ1.1 Types of data sources used systematically and
routinely to identify potential cases at a population-
based level
2.2 2.5 1.9
DQ1.2 Birth defects included using standard National
Birth Defects Prevention Network case definitions a
2.4 2.4 2.4
DQ1.3 Pregnancy outcomes included 2.1 2.7 1.8
DQ1.4 Systematic and routine identification of cases
during ascertainment period (age of diagnosis)
2.6 2.5 2.7
DQ1.5 Data elements collected a 1.8 2.0 1.6
Overall Completeness 2.2 2.4 2.1
DQ2: Timeliness DQ2.1 Time of case data completion for NBDPN
“core” list
1.8 1.7 1.9
DQ2.2 Time of case data completion for NBDPN
“recommended” list
1.5 1.4 1.5
Overall Timeliness 1.6 1.5 1.7
DQ3: Accuracy DQ3.1 Data quality procedures for verification of case
diagnosis
2.3 2.9 1.9
DQ3.2 Scope of birth defects verified 1.9 2.6 1.5
DQ3.3 Level of expertise for individuals who perform
case diagnosis verification
1.9 2.5 1.5
DQ3.4 Database quality assurance process 1.7 2.1 1.5
Overall Accuracy 2.0 2.5 1.6
Overall (All Measures) 2.0 2.3 1.8
aNBDPN list of birth defects and data elements are available at www.nbdpn.org
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measure 3.1 (data quality procedures for verification of
case diagnosis). Three performance measures for which
more than 75 % of the surveillance programs achieved at
least a level 2 included: data quality measure 1.1 (types
of data sources), 1.4 (systematic and routine identifica-
tion of cases), and 3.3 (level of expertise for individuals
who perform case diagnosis verification). The distribu-
tion of the scores for each data quality performance
measure by self-reported standard level for all participat-
ing programs is displayed in Fig. 1.
The average scores by program case-finding approach
for completeness, timeliness, and accuracy are also pre-
sented in Table 2. Surveillance programs using an active
case-finding approach, on the average, scored higher
than programs using a passive case-finding approach for
the completeness (2.4 vs. 2.1) and accuracy (2.5 vs. 1.6)
data quality performance measures, whereas their aver-
age score was lower for timeliness measures (1.5 vs. 1.7).
Discussion
This is the first systematic attempt in the United States
to comprehensively assess data quality (completeness,
timeliness, and accuracy) across birth defects surveil-
lance programs and provide information about areas for
improvement. Our a priori expectation was that most
programs would be able to achieve level 2 on all mea-
sures. In fact, the average score for each completeness
performance measure was above level 2, except for data
quality measure 1.5 (data elements collected). However,
the average score for both timeliness performance mea-
sures were below level 2, as were those for all but one
accuracy performance measure. Although all three data
quality attributes are important, we recognize the trade-
offs that programs might need to make to focus on
certain attributes instead of others given resource con-
straints. Further, because birth defects surveillance pro-
grams across the United States differ in methods, case
ascertainment, purpose, and resources, our standards
were designed to measure both the adequacy of methods
in place, as well as data quality. Our findings demon-
strated that all programs can enhance what they do and
that challenges were different for programs that used ac-
tive versus passive case-finding approaches; however, in
general, data quality was highest for those programs with
active case-finding approaches.
Other surveillance programs have established data
quality standards and demonstrated the value of such
improvements. Cancer registries in the United States
developed a system for setting cancer surveillance stan-
dards and for assessing the quality, completeness, and
timeliness of population-based cancer registries. The re-
sult is a system of certification for cancer registries that
employs accepted measurable data assessments, routine
methods for the auditing registry operations, and in the
Fig. 1 Distribution of score by data quality (DQ) standard level for each performance measure (n = 43)
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end, the ability to annually and efficiently assemble
complete information on cancer incidence across the
United States and its territories, as well as the provinces
and territories in Canada.
Data collection for U.S. vital statistics has had a long
history of national coordination. Standardized forms
were first developed in 1900, and model vital records
reporting statutes were first produced in 1907. Addition-
ally, the National Association of Public Health Statistics
and Information Systems (NAPHSIS), an organization of
state health statistics offices, has worked to develop uni-
formity and comparability in health statistics informa-
tion since 1933. These national efforts have translated
into four decades of comparable vital statistics data
within and across states that are routinely combined na-
tionally to monitor population changes, assess popula-
tion health, set and monitor progress in state and local
public health initiatives, and facilitate research.
Similarly, the European Surveillance of Congenital
Anomalies (EUROCAT) network of population-based birth
defect registries developed a set of data quality indicators
to assess completeness of case ascertainment, accuracy of
diagnosis, completeness of information on EUROCAT vari-
ables, timeliness of data transmission, and availability of
population denominator information [13]. EUROCAT and
the NBDPN are assessing similar aspects of surveillance
program data. However, our approach differs from EURO-
CAT in that they use more statistical metrics (i.e., percents,
prevalences, ratios), while we are measuring approaches
and methods that underlie these quantitative evaluations.
As an example, EUROCAT uses neural tube defect preva-
lence and spina bifida-to-anencephaly ratio to measure
under-ascertainment of birth defects cases among termina-
tions of pregnancy. The NBDPN tool assesses which preg-
nancy outcomes the surveillance program includes. Thus,
the NBPDN strategy is more qualitative and seeks to en-
courage the uniformity of methods across programs as a
first step in moving towards consistent, high quality birth
defects surveillance data in the United States.
The strengths of our effort include its high participa-
tion rate and the scope of input received in advance of
our rollout of the data quality assessment tool. Almost
one-half of the population-based birth defects surveil-
lance programs in the United States participated in pilot-
ing the assessment tool and provided feedback to our
workgroup. In addition, the standards were built on the
foundation of existing NBDPN birth defects surveillance
guidelines. Establishing guidelines was a necessary and
effective first phase in developing standards for our pro-
grams; moving from guidelines to standards has been
gradual. We now need to transition from guidelines to
national standards to increase the quality, comparability,
and utility of birth defects surveillance data. Finally,
based on the high participation rate and feedback from
programs, birth defects surveillance programs are inter-
ested and see the value of this initiative.
Our preliminary data are limited due to collection by
self-assessment with no evaluation component. In
addition, as this was our first U.S. assessment of birth
defects surveillance programs, the tool and process
continue to be improved; thus, these data serve as a
preliminary baseline against which future data collec-
tions can be compared. Another limitation is that the
data currently being collected to assess a surveillance
program are primarily an accounting of registry prac-
tices and procedures and not an actual assessment of
data quality and completeness. More formal surveil-
lance system assessments typically examine these pro-
gram attributes.
The development of national standards for birth de-
fects in the United States remains a work in-progress.
We considered 2014 a transition year, in which both
state programs and the NBDPN could examine how pro-
grams fare in meeting the standards and could imple-
ment improvements that will enable programs to
achieve more optimal standards. Programs can take
steps to improve their consistency with the NBDPN
standards, put processes in place to assist with achieving
national standards, and serve as champions raising
awareness about the value of national standards includ-
ing articulating the need for resources to achieve na-
tional standards. Together, the birth defects surveillance
community, working through the NBDPN, can develop
a uniform set of standards that can serve to promote
uniformity and enable surveillance programs to work to-
wards improving these programs. The long term benefit
will be improved and more comparable national data
which will allow us to take advantage of current and fu-
ture opportunities to better understand birth defects in
the U.S.
Conclusions
National standards for birth defects surveillance pro-
grams will allow for better pooling and translation of
surveillance data at the state, multi-state, and national
levels, thereby increasing the potential of these data to
inform critical public health questions. The progression
from recommended guidelines to established standards
for birth defects surveillance is a logical step in the evo-
lution of birth defects surveillance programs and offers
the potential to generate data that will be more current,
complete and accurate, as well as more uniform across
states. Currently, about one-half of the birth defects sur-
veillance programs in the United States meet the ess-
ential level of performance. Concerted efforts and
resources will be needed to achieve uniform high quality
national data.
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